Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 57.65B | 54.83B | 51.05B | 48.65B | 45.48B |
Gross Profit | 8.54B | 8.01B | 7.06B | 6.58B | 5.88B |
EBITDA | 2.97B | 3.20B | 3.42B | 3.08B | 2.66B |
Net Income | 997.00M | 1.17B | 103.00M | 1.08B | 791.00M |
Balance Sheet | |||||
Total Assets | 29.68B | 30.43B | 30.38B | 30.94B | 30.35B |
Cash, Cash Equivalents and Short-Term Investments | 6.28B | 6.98B | 6.63B | 5.48B | 4.68B |
Total Debt | 5.82B | 7.26B | 8.54B | 9.15B | 9.63B |
Total Liabilities | 14.54B | 15.48B | 16.35B | 16.75B | 16.93B |
Stockholders Equity | 15.13B | 14.95B | 14.03B | 14.18B | 13.42B |
Cash Flow | |||||
Free Cash Flow | 1.60B | 1.96B | 1.96B | 1.66B | 1.88B |
Operating Cash Flow | 3.21B | 3.67B | 2.97B | 2.59B | 3.17B |
Investing Cash Flow | -1.67B | -1.70B | -940.00M | -998.00M | -1.20B |
Financing Cash Flow | -2.25B | -1.62B | -879.00M | -792.00M | -320.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥17.71B | 11.13 | 2.63% | -2.63% | 3.18% | ||
74 Outperform | ¥16.49B | 17.14 | 1.73% | 6.40% | -11.56% | ||
63 Neutral | ¥22.15B | 14.20 | ― | 10.00% | 21.02% | ||
63 Neutral | ¥13.64B | 18.20 | 1.89% | 0.27% | -21.96% | ||
63 Neutral | $20.97B | 14.56 | -8.07% | 3.13% | 2.79% | -9.84% | |
61 Neutral | ¥12.09B | 108.90 | 1.38% | 10.84% | -18.43% | ||
61 Neutral | ¥13.77B | 24.63 | 0.31% | 4.29% | ― |